Medicare Enrolled

Dr. Keith Eyre, M.D.

Radiology - Diagnostic · San Antonio, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
4383 MEDICAL DR, San Antonio, TX 78229
2105935700
In practice since 2006 (19 years)
NPI: 1841223351 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Eyre from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Eyre? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Eyre

Dr. Keith Eyre is a radiology - diagnostic in San Antonio, TX, with 19 years in practice. Based on federal Medicare data, Dr. Eyre performed 6,542 Medicare services across 2,007 unique beneficiaries.

Between the years covered by Open Payments, Dr. Eyre received a total of $111 from 6 pharmaceutical and/or device companies across 8 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiology - diagnostic. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Eyre is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 18% volume in TX$ $111 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,542
Medicare services
Top 18% in TX for radiology - diagnostic
2,007
Unique beneficiaries
$170
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~344 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy1,217$29$114
Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session1,202$272$1,073
Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev730$178$678
Calculation of radiation therapy dose590$51$192
Continuing radiation therapy consultation per week577$65$247
Radiation treatment management, 5 treatment sessions497$148$561
Design and construction of complex radiation treatment device315$95$365
Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev307$178$680
Complex radiation therapy planning145$130$496
New patient office visit (45-59 min)126$120$486
CT guidance for radiation therapy112$84$320
Design and construction of radiation treatment device for high precision radiation therapy93$356$1,355
Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved92$339$1,312
Obtaining data needed to develop the optimal radiation treatment, 1 treatment area91$205$782
X-ray during radiation therapy79$10$39
High precision radiation therapy planning63$1,402$5,334
Complex radiation therapy planning for delivery of external radiation47$220$836
Image-guided robotic linear accelerator-based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatme47$1,531$20,000
3d radiation therapy planning41$367$1,526
Office visit, established patient (30-39 min)39$93$373
Special radiation treatment32$107$627
Image-guided robotic linear accelerator-based stereotactic radiosurgery, complete course of therapy in one session or first session of fractionated treatment30$2,036$30,000
Design and construction of simple radiation treatment device28$27$128
Management of cranial lesion surgery using radiation over multiple sessions26$496$1,886
Special radiation therapy planning16$47$190
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.6% high complexity
77.5% medium
20.9% routine

Industry Payment Transparency

Open Payments through 2022 ↗
$111
Total received (2018-2022)
Avg $28/year across 4 years
Bottom 14% in TX for radiology - diagnostic
6
Companies
8
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$111 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2022
$17
2020
$14
2019
$54
2018
$26

Payments by company (2022)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$40
SERVIER PHARMACEUTICALS LLC
$17
Bayer HealthCare Pharmaceuticals Inc.
$15
JAZZ PHARMACEUTICALS INC.
$14
Jazz Pharmaceuticals Inc.
$14
E.R. Squibb & Sons, L.L.C.
$11
Top 3 companies account for 64.4% of total payments
Associated products mentioned in payments ›
JADENU · OPDIVO · PROMACTA · RYDAPT · TIBSOVO · VYXEOS · Xofigo
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $2 per 100 Medicare services performed
Looking for a radiology - diagnostic in San Antonio?
Compare radiology - diagnostics in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse radiology - diagnostics nearby

Geographic Context

Radiology - Diagnostics within 10 mi
29
Per 100K population
1.4
County median income
$70,571
Nearest hospital
UNIVERSITY HEALTH SYSTEM
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2022
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Eyre is a clinical cardiology specialist, with above-average Medicare volume (top 18% in TX), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Eyre experienced with stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy?
Based on Medicare claims data, Dr. Eyre performed 1,217 stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Eyre receive payments from pharmaceutical companies?
Yes. Dr. Eyre received a total of $111 from 6 companies across 8 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Eyre's costs compare to other radiology - diagnostics in San Antonio?
Dr. Eyre's average Medicare payment per service is $170. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Eyre) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →